Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Preferred Shares (2017 - 2025)

Sunshine Biopharma's Preferred Shares history spans 10 years, with the latest figure at $13000.0 for Q4 2025.

  • For Q4 2025, Preferred Shares changed 0.0% year-over-year to $13000.0; the TTM value through Dec 2025 reached $13000.0, changed 0.0%, while the annual FY2025 figure was $13000.0, 0.0% changed from the prior year.
  • Preferred Shares reached $13000.0 in Q4 2025 per SBFM's latest filing, roughly flat from $13000.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $100000.0 in Q1 2021 to a low of $1000.0 in Q1 2022.
  • Average Preferred Shares over 5 years is $25600.0, with a median of $13000.0 recorded in 2024.
  • Peak YoY movement for Preferred Shares: crashed 99.0% in 2022, then skyrocketed 1200.0% in 2024.
  • A 5-year view of Preferred Shares shows it stood at $100000.0 in 2021, then plummeted by 99.0% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then surged by 1200.0% to $13000.0 in 2024, then changed by 0.0% to $13000.0 in 2025.
  • Per Business Quant, the three most recent readings for SBFM's Preferred Shares are $13000.0 (Q4 2025), $13000.0 (Q3 2025), and $13000.0 (Q2 2025).